Trial Profile
Multi-center,Randomized,Double Blind, Double Dummy,Placebo Controlled, Efficacy and Safety Study of HS-25 in Combination With Atovastatin in Adults With Primary Hypercholesterolemia
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Hyzetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Zhejiang Hisun Pharmaceutical
- 17 Oct 2018 Planned primary completion date changed from 28 Aug 2018 to 28 Dec 2018.
- 16 Mar 2018 New trial record